熱門資訊> 正文
MYMD、MDIA和LIFW是上市前上涨股之一
2024-04-09 20:48
- Gainers: Acrivon Therapeutics (ACRV) +75% Announces $130 Million Private Placement Financing.
- Laser Photonics (LASE) +66% Secures Order From L3Harris Technologies for LaserTower Marking & Engraving System.
- MyMD Pharmaceuticals (MYMD) +35%.
- Molecular Templates (MTEM) +25% Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer Patients Observed Through Novel Immuno-oncology Mechanism.
- Rail Vision (RVSN) +21%.
- Addex Therapeutics (ADXN) +20%.
- Pineapple Financial (PAPL) +20%.
- Vivos Therapeutics (VVOS) +22% files to sell 1.73M shares of common stock for holders.
- Aterian (ATER) +19% Partners with Mercado Libre, Latin America’s Leading E-Commerce Platform
- Anghami (ANGH) +14%.
- MediaCo (MDIA) +11%.
- MSP Recovery (LIFW) +11%.
- AGM Group Holdings (AGMH) +10% Enters Strategic Partnership with AI Service Provider RDA to Construct AI Data Centers.
- Shengfeng Development (SFWL) +7%.
- Taysha Gene Therapies (TSHA) +7%.
- Sasol (SSL) +7%.
- Marti Technologies (MRT) +6%.
More on premarket gainers & stock
- MyMD Pharmaceuticals down after announcing reverse stock split
- Financial information for MSP Recovery
- Financial information for Mediaco
- Financial information for MyMD Pharmaceuticals
- Compare metrics for LIFW to MDIA, MYMD
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。